A Multicenter Phase III Randomised Trial comparing Total Mesorectal Excision with Pre-operative Radiotherapy with or without Post-operative Oral Capecitabine in the Treatment of Operable Primary Rectal Cancer.

Trial Profile

A Multicenter Phase III Randomised Trial comparing Total Mesorectal Excision with Pre-operative Radiotherapy with or without Post-operative Oral Capecitabine in the Treatment of Operable Primary Rectal Cancer.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 01 Mar 2016

At a glance

  • Drugs Capecitabine (Primary)
  • Indications Rectal cancer
  • Focus Therapeutic Use
  • Acronyms PROCTOR-SCRIPT; SCRIPT
  • Most Recent Events

    • 29 Sep 2015 Status changed from active, no longer recruiting to discontinued.
    • 06 Jan 2010 New source identified and integrated (Netherlands Trial Register, NTR552).
    • 11 Aug 2009 Official title amended as reported by ISRCTN: Current Controlled Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top